Inhibition of BRCC36 enhances apoptosis by disrupting BRCA1 phosphorylation in breast cancer cells exposed to ionizing radiation.

被引：0
|
作者：
Arciero, CA [1 ]
Chen, X [1 ]
Godwin, AK [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S284 / S284
页数：1
相关论文
共 45 条
  • [31] Transcriptional Profiling of Breast Cancer Cells Exposed to Soy Phytoestrogens After BRCA1 Knockdown With a Whole Human Genome Microarray Approach
    Satih, Samir
    Chalabi, Nassera
    Rabiau, Nadege
    Bignon, Yves-Jean
    Bernard-Gallon, Dominique J.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (05): : 659 - 667
  • [32] Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status
    Thasni, Karedath Abdul Aziz
    Rojini, Gopakumaran
    Rakesh, S. Nair
    Ratheeshkumar, Thankappan
    Babu, Mani Shankar
    Srinivas, Gopala
    Banerji, Asoke
    Srinivas, Priya
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 588 (2-3) : 158 - 164
  • [33] Relationship of ionizing radiation-induced synthetic lethality of PARP inhibition in BRCA1-proficient cancer cells with p53
    Sizemore, Steven T.
    Mohammad, Rahman
    Sizemore, Gina M.
    Yu, Hao
    Ostrowski, Michael C.
    Chakravarti, Arnab
    Xia, Fen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] A novel BRCA1 germline mutation promotes triple-negative breast cancer cells progression and enhances sensitivity to DNA damage agents
    Xu, Kun
    Shi, Yaqin
    Wang, Xin
    Chen, Yajuan
    Tang, Lin
    Guan, Xiaoxiang
    CANCER GENETICS, 2019, 239 : 26 - 32
  • [35] Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells
    Liu, Guilai
    Honisch, Sabina
    Liu, Guoxing
    Schmidt, Sebastian
    Pantelakos, Stavros
    Alkahtani, Saad
    Toulany, Mahmoud
    Lang, Florian
    Stournaras, Christos
    CANCER BIOLOGY & THERAPY, 2015, 16 (01) : 52 - 59
  • [36] Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition
    Kimbung, Siker
    Biskup, Ewa
    Johansson, Ida
    Aaltonen, Kristina
    Ottosson-Wadlund, Astrid
    Gruvberger-Saal, Sofia
    Cunliffe, Heather
    Fadeel, Bengt
    Loman, Niklas
    Berglund, Pontus
    Hedenfalk, Ingrid
    CANCER LETTERS, 2012, 319 (02) : 232 - 241
  • [37] c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells
    Chai, YL
    Chipitsyna, G
    Cui, JQ
    Liao, BS
    Liu, S
    Aysola, K
    Yezdani, M
    Reddy, ESP
    Rao, VN
    ONCOGENE, 2001, 20 (11) : 1357 - 1367
  • [38] c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells
    YuLi Chai
    Galina Chipitsyna
    Jianqi Cui
    Boshan Liao
    Shuang Liu
    Kartik Aysola
    Mona Yezdani
    E Shyam P Reddy
    Veena N Rao
    Oncogene, 2001, 20 : 1357 - 1367
  • [39] Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (vol 134, pg 511, 2012)
    Pessetto, Ziyan Yuan
    Yan, Ying
    Bessho, Tadayoshi
    Natarajan, Amarnath
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 613 - 613
  • [40] Combined effects of soy phytoestrogen exposure and BRCA1 knockdown on apoptosis-related genes in breast cancer cells with a whole human genome microarray approach
    Satih, S.
    Chalabi, N.
    Rabiau, N.
    Bignon, Y. J.
    Bernard-Gallon, D. J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 14 - 14
12345